Literature DB >> 21531044

Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease.

Lifen Zhang1, Weidong Le, Wenjie Xie, John A Dani.   

Abstract

The nuclear receptor related 1 (Nurr1) transcription factor contributes to the development and maintenance of dopamine (DA) neurons in the brain. We found that heterozygous Nurr1 knockout (Nurr1 +/-) influenced the age-dependent decline in the number of DA neurons and influenced DA signaling. We examined the DA marker, tyrosine hydroxylase, using immunohistochemistry, and we measured DA signaling using fast-scan cyclic voltammetry in 3 age groups of wild-type (Nurr1 +/+) and mutant (Nurr1 +/-) mice: 3-6, 9-12, and 15-23 mo old. Prior to significant loss of DA neurons and to the onset of parkinsonian symptoms, young Nurr1 +/- mice (3-6 mo) exhibited a decrease in peak evoked DA release that was partially countered by a decrease in the rate of DA reuptake. As peak evoked DA release declined with age for both the wild-type and Nurr1 +/- mice, both genotypes manifested decreased DA reuptake. As the DA release fell further with age, decreased DA reuptake eventually could not adequately compensate the Nurr1 +/- mice. The results indicated that Nurr1 deficiency led to impaired DA release even before significant DA neuron loss. Copyright Â
© 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531044      PMCID: PMC3155628          DOI: 10.1016/j.neurobiolaging.2011.03.022

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  51 in total

1.  Aging of the rat mesostriatal system: differences between the nigrostriatal and the mesolimbic compartments.

Authors:  Ignacio Cruz-Muros; Domingo Afonso-Oramas; Pedro Abreu; Pedro Barroso-Chinea; Manuel Rodríguez; M Carmen González; Tomás González Hernández
Journal:  Exp Neurol       Date:  2006-11-16       Impact factor: 5.330

Review 2.  The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease.

Authors:  J Jankovic; S Chen; W D Le
Journal:  Prog Neurobiol       Date:  2005-10-21       Impact factor: 11.685

3.  Nurr1 in Parkinson's disease and related disorders.

Authors:  Yaping Chu; Weidong Le; Katie Kompoliti; Joseph Jankovic; Elliott J Mufson; Jeffrey H Kordower
Journal:  J Comp Neurol       Date:  2006-01-20       Impact factor: 3.215

4.  Aging-related changes in the nigrostriatal dopamine system and the response to MPTP in nonhuman primates: diminished compensatory mechanisms as a prelude to parkinsonism.

Authors:  Timothy J Collier; Jack Lipton; Brian F Daley; Stephane Palfi; Yaping Chu; Caryl Sortwell; Roy A E Bakay; John R Sladek; Jeffrey H Kordower
Journal:  Neurobiol Dis       Date:  2007-01-23       Impact factor: 5.996

5.  Translated mutation in the Nurr1 gene as a cause for Parkinson's disease.

Authors:  David A Grimes; Fabin Han; Michel Panisset; Lemuel Racacho; Fengxia Xiao; Ruobing Zou; Kelly Westaff; Dennis E Bulman
Journal:  Mov Disord       Date:  2006-07       Impact factor: 10.338

6.  Nurr1 transcriptionally regulates the expression of alpha-synuclein.

Authors:  Yan Xiang Yang; David S Latchman
Journal:  Neuroreport       Date:  2008-05-28       Impact factor: 1.837

7.  Selective agenesis of mesencephalic dopaminergic neurons in Nurr1-deficient mice.

Authors:  W Le; O M Conneely; L Zou; Y He; O Saucedo-Cardenas; J Jankovic; D R Mosier; S H Appel
Journal:  Exp Neurol       Date:  1999-10       Impact factor: 5.330

8.  Age-dependent dopaminergic dysfunction in Nurr1 knockout mice.

Authors:  Chuantao Jiang; Xinhua Wan; Yi He; Tianhong Pan; Joseph Jankovic; Weidong Le
Journal:  Exp Neurol       Date:  2005-01       Impact factor: 5.330

9.  Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens.

Authors:  Richard Exley; Michael A Clements; Henrike Hartung; J Michael McIntosh; Stephanie J Cragg
Journal:  Neuropsychopharmacology       Date:  2007-11-21       Impact factor: 7.853

10.  Age-related differences in levodopa dynamics in Parkinson's: implications for motor complications.

Authors:  Vesna Sossi; Raúl de la Fuente-Fernández; Michael Schulzer; John Adams; Jon Stoessl
Journal:  Brain       Date:  2006-02-13       Impact factor: 13.501

View more
  20 in total

1.  Ex Vivo Measurement of Electrically Evoked Dopamine Release in Zebrafish Whole Brain.

Authors:  Mimi Shin; Thomas M Field; Chase S Stucky; Mia N Furgurson; Michael A Johnson
Journal:  ACS Chem Neurosci       Date:  2017-06-28       Impact factor: 4.418

2.  Nurr1:RXRα heterodimer activation as monotherapy for Parkinson's disease.

Authors:  Athanasios D Spathis; Xenophon Asvos; Despina Ziavra; Theodoros Karampelas; Stavros Topouzis; Zoe Cournia; Xiaobing Qing; Pavlos Alexakos; Lisa M Smits; Christina Dalla; Hardy J Rideout; Jens Christian Schwamborn; Constantin Tamvakopoulos; Demosthenes Fokas; Demetrios K Vassilatis
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-27       Impact factor: 11.205

Review 3.  Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.

Authors:  Jaclyn Nicole Le Grand; Laura Gonzalez-Cano; Maria Angeliki Pavlou; Jens C Schwamborn
Journal:  Cell Mol Life Sci       Date:  2014-11-18       Impact factor: 9.261

4.  Covalent Modification and Regulation of the Nuclear Receptor Nurr1 by a Dopamine Metabolite.

Authors:  John M Bruning; Yan Wang; Francesca Oltrabella; Boxue Tian; Svetlana A Kholodar; Harrison Liu; Paulomi Bhattacharya; Su Guo; James M Holton; Robert J Fletterick; Matthew P Jacobson; Pamela M England
Journal:  Cell Chem Biol       Date:  2019-03-07       Impact factor: 8.116

5.  Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease.

Authors:  N J Butcher; M K Horne; G D Mellick; C J Fowler; C L Masters; R F Minchin
Journal:  Pharmacogenomics J       Date:  2017-04-04       Impact factor: 3.550

6.  Nurr1 Is Not an Essential Regulator of BDNF in Mouse Cortical Neurons.

Authors:  Mona Abdollahi; Margaret Fahnestock
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

7.  Nuclear receptor 4A (NR4A) family - orphans no more.

Authors:  Stephen Safe; Un-Ho Jin; Benjamin Morpurgo; Ala Abudayyeh; Mandip Singh; Ronald B Tjalkens
Journal:  J Steroid Biochem Mol Biol       Date:  2015-04-23       Impact factor: 4.292

8.  Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.

Authors:  Weidong Le; Lifen Zhang; Wenjie Xie; Song Li; John A Dani
Journal:  Neurobiol Aging       Date:  2015-08-20       Impact factor: 4.673

Review 9.  Molecular Insights into NR4A2(Nurr1): an Emerging Target for Neuroprotective Therapy Against Neuroinflammation and Neuronal Cell Death.

Authors:  Md Jakaria; Md Ezazul Haque; Duk-Yeon Cho; Shofiul Azam; In-Su Kim; Dong-Kug Choi
Journal:  Mol Neurobiol       Date:  2019-01-25       Impact factor: 5.590

Review 10.  Parkinson's disease: experimental models and reality.

Authors:  Peizhou Jiang; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2017-11-18       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.